EUVIMEDEUVIMED entdecken
Beobachtungsstudie

Critically Ill Patients with COVID-19 Pneumonia Requiring Continuous Renal Replacement Therapy with oXiris® Membrane in a Third-Level Hospital in Northeast Mexico

Paola Borbolla-Flores, Luz Yareli Villegas-Gutiérrez, Bruno Maximiliano Samaniego-Segovia, Francisco Javier Torres-Quintanilla, Juan Pablo Gómez-Villarreal, Ricardo Abraham Garza-Treviño, Lilia María Rizo-Topete

Blood Purification · 2024

DOI: 10.1159/000539481 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Blood Purification, 2024. Verfasst von Paola Borbolla-Flores und 6 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Christus Muguerza Alta Especialidad, Universidad de Monterrey, UDEM, San Pedro Garza García, Mexico. Hauptthemen laut MEDLINE: Acute Kidney Injury, Continuous Renal Replacement Therapy, COVID-19. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The coronavirus disease 2019 (COVID-19) pandemic represented a global public health problem with devastating consequences that have challenged conventional medical treatments. Continuous renal replacement therapy (CRRT), based on a spectrum of modalities and dialysis membranes, can modify cytokine storms, and improve the clearance of inflammatory factors. As severe COVID-19 can lead to acute kidney injury (AKI) requiring RRT, most patients require more than one extracorporeal organ support at this point. This is due to complications that lead to organ dysfunction. The aim of our study was to assess renal recovery and survival while use of the oXiris membrane, as well as a decrease in vasopressors and hemodynamic parameters.

Methods

This was a retrospective, observational study. The population included adult patients (aged >18 years) with a real-time PCR COVID-19 positive test, admitted to the intensive care unit (ICU) with AKI KDIGO 3, which required CRRT, in a hospital in northern Mexico. The primary outcomes were renal recovery and survival, and the secondary outcomes were a decrease in the vasopressor requirements and changes in the hemodynamic parameters.

Results

Thirteen patients were included from January 2020 to August 2021, all of whom met the inclusion criteria. oXiris, an AN69-modified membrane, was used for blood purification and cytokine storm control in all the patients. The primary outcome, renal recovery, and survival were observed in 23% of the patients. The secondary outcome was a decrease of 12% in the use of noradrenaline in the first 24 h of CRRT initiation with oXiris, in addition to a decrease in creatinine and C-reactive protein levels in all patients.

Discussion

The use of the oXiris membrane in patients with severe COVID-19 improved hemodynamic parameters, with 23% of the patients achieving renal recovery. The decrease on the requirement of vasopressors in the overall patients in the first 24 h of CRRT with oXiris was achieved. The mean decrease was of 12%, accompanied by a decrease in inflammatory markers. There is literature on the benefit of CRRT with a modified AN69 membrane in Mexico; however, studies in this regard are scarce, and our research provides valuable information on our experience in this field.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Acute Kidney InjuryContinuous Renal Replacement TherapyCOVID-19AdultAgedFemaleHumansMaleMiddle AgedCritical IllnessHemodynamicsIntensive Care UnitsMembranes, ArtificialMexicoRenal Replacement TherapyRetrospective StudiesSARS-CoV-2Tertiary Care CentersVasoconstrictor Agents

Stichwörter der Autor:innen

Acute kidney injuryCOVID-19Continuous renal replacement therapyoXiris

Substanzen

Membranes, ArtificialVasoconstrictor Agents

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Christus Muguerza Alta Especialidad, Universidad de Monterrey, UDEM, San Pedro Garza García, Mexico.
  • Internal Medicine Department and Nephrology Service, Hospital Universitario "José Eleuterio González," Universidad Autónoma de Nuevo León, UANL, San Nicolás de los Garza, Mexico.
  • Nephrology Department, Hospital Regional Dr. Valentín Gómez Farías, Institute for Social Security and Services for State Workers, Zapopan, Mexico.

Zitieren

APA

Borbolla-Flores, P., Villegas-Gutiérrez, L. Y., Samaniego-Segovia, B. M., Torres-Quintanilla, F. J., Gómez-Villarreal, J. P., Garza-Treviño, R. A., & Rizo-Topete, L. M. (2024). Critically Ill Patients with COVID-19 Pneumonia Requiring Continuous Renal Replacement Therapy with oXiris® Membrane in a Third-Level Hospital in Northeast Mexico. Blood Purification. https://doi.org/10.1159/000539481

Vancouver

Borbolla-Flores P, Villegas-Gutiérrez LY, Samaniego-Segovia BM, Torres-Quintanilla FJ, Gómez-Villarreal JP, Garza-Treviño RA, et al. Critically Ill Patients with COVID-19 Pneumonia Requiring Continuous Renal Replacement Therapy with oXiris® Membrane in a Third-Level Hospital in Northeast Mexico. Blood Purification. 2024. doi:10.1159/000539481

BibTeX
@article{BorbollaFlores2024,
  author = {Borbolla-Flores, Paola and Villegas-Gutiérrez, Luz Yareli and Samaniego-Segovia, Bruno Maximiliano and Torres-Quintanilla, Francisco Javier and Gómez-Villarreal, Juan Pablo and Garza-Treviño, Ricardo Abraham and Rizo-Topete, Lilia María},
  title = {Critically Ill Patients with COVID-19 Pneumonia Requiring Continuous Renal Replacement Therapy with oXiris® Membrane in a Third-Level Hospital in Northeast Mexico},
  journal = {Blood Purification},
  year = {2024},
  doi = {10.1159/000539481}
}
Kostenlos starten →